Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder

Journal of Psychiatric Research

Volumn 47, Issue 9, 2013, Pages 1199-1203

  Garlow, Steven J ^a   Kinkead, Becky ^a   Thase, Michael E ^b   Judd, Lewis L ^c   Rush, A John ^d   Yonkers, Kimberly A ^e   Kupfer, David J ^f   Frank, Ellen ^f   Schettler, Pamela J ^a   Rapaport, Mark Hyman ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antidepressant; Fluoxetine; Minor depressive disorder; Treatment emergent suicide ideation

Indexed keywords

FLUOXETINE; PLACEBO;

ARTICLE; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESEARCH SUBJECT; SUICIDAL IDEATION; SYMPTOM CHECKLIST 90; TREATMENT DURATION;

EID: 84880131586     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.05.025     Document Type: Article

References (38)

1. Barbui C., Esposito E., Cipriani A. Selective serotonin reuptake inhibitors an risk of suicide: a systematic review of observational studies. Canadian Medical Association Journal 2009, 180(3):291-297.
2. Beasley C.M., Ball S., Nilsson M.E., Polzer J., Tauscher-Wisniewski S., Plewes J., et al. Fluoxetine and adult suicidality revisited. Journal of Clinical Psychopharmacology 2007, 27:682-686.
3. Beasley C.M., Dornseif B.E., Bosomworth J.C., Sayler M.E., Rampey A.H., Heiligenstein J.H., et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal 1991, 303(6804):685-692.
4. Beasley C.M., Potvin J.H., Masica D.N., Wheadon D.E., Dornseif B.E., Genduso L.A. Fluoxetine: no association with suicidality in obsessive-compulsive disorder. Journal of Affective Disorders 1992, 24(1):1-10.
5. Carpenter D.J., Fong R., Kraus J.E., Davies J.T., Moore C., Thase M.E. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials. Journal of Clinical Psychiatry 2011, 72(11):1503-1514.
6. Dasgupta K. Additional cases of suicidal ideation associated with fluoxetine. American Journal of Psychiatry 1990, 147(11):1570.
7. Derogatis L.R., Lipman R.S., Covi L. SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacology Bulletin 1973, 9:13-28.
8. Gibbons R.D., Brown C.H., Hur K., Bhaumik D.K., Mann J.J. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. American Journal of Psychiatry 2007, 164(7):1044-1049.
9. Gibbons R.D., Brown H., Hur K., Davis J.M., Mann J.J. Suicidal thoughts and behavior with antidepressant treatment. Archives of General Psychiatry 2012, 69(6):580-587.
10. Gibbons R.D., Hur K., Bhaumik D.K., Mann J.J. The relationship between antidepressant medication use and rate of suicide. Archives of General Psychiatry 2005, 62(2):165-172.
11. Goldstein D.J., Rampey A.H., Potvin J.H., Masica D.N., Beasley C.M. Analysis of suicidality in double-blind, placebo controlled trials of pharmacotherapy for weight reduction. Journal of Clinical Psychiatry 1993, 54(8):309-316.
12. Hamilton M. Arating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960, 23:56-62.
13. Hammad T., Laughren T., Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 2006, 63:332-339.
14. Healy D. The fluoxetine and suicide controversy: a review of the evidence. CNS Drugs 1994, 1(3):223-231.
15. Healy D., Langmaak C., Savage M. Suicide in the course of treatment of depression. Journal of Psychopharmacology 1999, 13(1):94-99.
16. Healy D., Whitaker C. Antidepressants and suicide: risk-benefit conundrums. Journal of Psychiatry and Neuroscience 2003, 28(5):331-337.
17. Hoover C.E. Additional cases of suicidal ideation associated with fluoxetine. American Journal of Psychiatry 1990, 147(11):1570-1571.
18. Isacsson G., Bergman U., Rich C.L. Epidemiological data suggest antidepressants reduce suicide risk among depressives. Journal of Affective Disorders 1996, 41(1):1-8.
19. Judd L.L., Rapaport M.H., Yonkers K.A., Rush A.J., Frank E., Thase M.E., et al. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. American Journal of Psychiatry 2004, 161:1864-1871.
20. Khan A., Khan S.R., Kolts R., Brown W.A. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. American Journal of Psychiatry 2003, 160:790-792.
21. Khan A., Warner H.A., Brown W.A. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Archives of General Psychiatry 2000, 57(4):311-317.
22. Lapierre Y.D. Suicidality with selective serotonin reuptake inhibitors: valid claim?. Journal of Psychiatry and Neuroscience 2003, 28(5):340-347.
23. Leon A.C., Solomon D.A., Li C., Fiedorowicz J.G., Coryell W., Endicott J., et al. Antidepressants and risks of suicide and suicide attempts: a 27 year observational study. Journal of Clinical Psychiatry 2011, 72(5):580-586.
24. Masand P., Gupta S., Dewan M. Suicidal ideation related to fluoxetine treatment. New England Journal of Medicine 1991, 324(6):420.
25. Milane M.S., Suchard M.A., Wong M.L., Licino J. Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States. PLoS Medicine 2006, 3(6):e190.
26. Nakagawa A., Grunebaum M.F., Ellis S.P., Oquendo M.A., Kashima H., Gibbons R.D., et al. Association of suicide and antidepressant prescription rates in Japan, 1999-2003. Journal of Clinical Psychiatry 2007, 68(6):908-916.
27. Phillips K.A., Kelly M.M. Suicidality in placebo-controlled fluoxetine study of body dysmorphic disorder. International Clinical Psychopharmacology 2009, 24:26-28.
28. Rapaport M.H., Judd L.L., Schettler P.J., Yonkers K.A., Thase M.E., Kupfer D.J., et al. Adescriptive analysis of minor depression. American Journal of Psychiatry 2002, 159:637-643.
29. Rush A.J., Giles D.E., Schlesser M.A., Fulton C.L., Weissenburger J., Burns C. The Inventory of Depressive Symptomatology (IDS): preliminary findings. Psychiatry Research 1986, 18:65-87.
30. Simon G.E., Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. American Journal of Psychiatry 2007, 164:1029-1034.
31. Szanto K., Mulsant B., Houck P., Dew M.A., Reynolds C.F. Occurrence and course of suicidality during short-term treatment of late-life depression. Archives of General Psychiatry 2003, 60:610-617.
32. Tauscher-Wisniewski S., Disch D., Plewes J., Ball S., Beasley C.M. Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder. Psychological Medicine 2007, 37(11):1585-1593.
33. Teicher M.H., Glod C., Cole J.O. Emergence of intense suicidal proccupation during treatment fluoxetine treatment. American Journal of Psychiatry 1990, 147(2):207-210.
34. Tollefson G.D., Fawcett J., Winokur G., Beasley C.M., Potvin J.H., Faries D.E., et al. Evaluation of suicidality during pharmacologic treatment of mood and non mood disorders. Annals of Clinical Psychiatry 1993, 5(4):209-224.
35. Suicidality and antidepressant drugs 2007, US Food and Drug Administration. http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM173233.pdf.
36. Warshaw M.G., Keller M.B. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. Journal of Clinical Psychiatry 1996, 57(4):158-166.
37. Wheadon D.E., Rampey A.H., Thompson V.L., Potvin J.H., Masica D.N., Beasley C.M. Lack of association between fluoxetine and suicidality in bulimia nervosa. Journal of Clinical Psychiatry 1992, 53(7):):235-241.
38. Wightman D.S., Foster V.J., Krishen A., Richard N.E., Modell J.G. Meta-analysis of suicidality in placebo-controlled clinical trials of adults taking bupropion. Journal of Clinical Psychiatry 2010, 12(5):1-8.